Stephan Dietrich A Insider Trades

Insider Trading History

Track insider trading activity for Stephan Dietrich A. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
NeuBase Therapeutics
NeuBase Therapeutics NBSE
10% owner, Founder And CEO
Holding Value $0 0 shares
Last Trade
Aug 02, 2023 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$114k 93,234 shares
$1.22
$0.38
NeuBase Therapeutics
NeuBase Therapeutics NBSE
10% owner, Founder And CEO
Holding Value $35.2k 93,234 shares
Last Trade
Aug 02, 2023 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$114k 93,234 shares
$1.22
$0.38
NeuBase Therapeutics
NeuBase Therapeutics NBSE
10% owner, CEO And Director
Holding Value $57.8k 153,000 shares
Last Trade
Mar 16, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$12.2M 153,000 shares
$79.92
$0.38
NeuBase Therapeutics
NeuBase Therapeutics NBSE
10% owner, President And CEO
Holding Value $705k 1,864,680 shares
Last Trade
Feb 13, 2023 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$102M 655,000 shares
$156.00
$0.38
NeuBase Therapeutics
NeuBase Therapeutics NBSE
10% owner, President And CEO
Holding Value $556k 1,471,775 shares
Last Trade
Feb 13, 2023 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$102M 655,000 shares
$156.00
$0.38
NeuBase Therapeutics
NeuBase Therapeutics NBSE
CEO
Holding Value $952k 2,519,680 shares
Last Trade
Sep 28, 2022 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$122M 750,000 shares
$162.40
$0.38
NeuBase Therapeutics
NeuBase Therapeutics NBSE
10% owner, President And CEO
Holding Value $116k 306,000 shares
Last Trade
Jan 24, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$193M 306,000 shares
$632.00
$0.38
NeuBase Therapeutics
NeuBase Therapeutics NBSE
10% owner, President And CEO
Holding Value $25.2k 66,775 shares
Last Trade
Dec 31, 2021 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$47.5M 42,250 shares
$1,124.00
$0.38
NeuBase Therapeutics
NeuBase Therapeutics NBSE
10% owner, President And CEO
Holding Value $1.24M 3,269,680 shares
Last Trade
Dec 31, 2021 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$47.5M 42,250 shares
$1,124.00
$0.38
NeuBase Therapeutics
NeuBase Therapeutics NBSE
10% owner, President And CEO
Holding Value $9.27k 24,525 shares
Last Trade
Apr 26, 2021 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$27.4M 12,000 shares
$2,280.00
$0.38
NeuBase Therapeutics
NeuBase Therapeutics NBSE
10% owner, President And CEO
Holding Value $62.3k 164,925 shares
Last Trade
Dec 29, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$457M 164,925 shares
$2,768.00
$0.38
NeuBase Therapeutics
NeuBase Therapeutics NBSE
10% owner, President And CEO
Holding Value $963k 2,547,639 shares
Last Trade
Dec 01, 2020 Sale (Gift)Shares transferred as a gift rather than bought or sold for cash.
$7.76B 2,547,639 shares
$3,044.00
$0.38
NeuBase Therapeutics
NeuBase Therapeutics NBSE
10% owner, President And CEO
Holding Value $4.73k 12,525 shares
Last Trade
Jun 09, 2020 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$3.82M 1,275 shares
$2,996.00
$0.38
NeuBase Therapeutics
NeuBase Therapeutics NBSE
10% owner, President And CEO
Holding Value $4.25k 11,250 shares
Last Trade
May 21, 2020 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$4.09M 1,250 shares
$3,268.00
$0.38
NeuBase Therapeutics
NeuBase Therapeutics NBSE
10% owner, President And CEO
Holding Value $3.78k 10,000 shares
Last Trade
Apr 30, 2020 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$30.4M 10,000 shares
$3,036.00
$0.38
NeuBase Therapeutics
NeuBase Therapeutics NBSE
10% owner, President And CEO
Holding Value $1.25M 3,311,930 shares
Last Trade
Jul 12, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$31.6M 5,859,569 shares
$5.39
$0.38

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up